Anti-IL-13 Receptor α2, Human, Goat-Poly

データシート※最新のデータシートでない場合があります

• 商品コード：AF146
• メーカー：RSD
• 包装：100μg
• 価格： ¥106,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Trieu Y et al. Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivo. Cancer Res. 2004 May;64(9):3271-5
  Trieu Y et al
  2004/01/01
  
• 備考：
  monkey COS-7 SV40-transformed kidney fibroblasts transfected with human IL-13 R2
• 参照：
  

• No.： 2
• 文献情報：
  Jakubzick C et al. Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia. Am. J. Pathol. 2004 Jun;164(6):1989-2001
  Jakubzick C et al
  2004/01/01
  
• 備考：
  Application: Neutralization, Sample Type: Whole Cells
• 参照：
  

• No.： 3
• 文献情報：
  Fujitsu Y et al. Protection of human conjunctival fibroblasts from NO-induced apoptosis by interleukin-4 or interleukin-13. Invest. Ophthalmol. Vis. Sci. 2005 Mar;46(3):797-802
  Fujitsu Y et al
  2005/01/01
  
• 備考：
  Application: Flow Cytometry, Sample Type: Whole Cells
• 参照：
  

• No.： 4
• 文献情報：
  Daines MO et al. Level of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling. J. Immunol. 2006 Jun;176(12):7495-501
  Daines MO et al
  2006/01/01
  
• 備考：
  Species: Human, Application: Flow Cytometry, Sample type: Whole Cells
• 参照：
  

• No.： 5
• 文献情報：
  Andrews AL et al. IL-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts. J. Allergy Clin. Immunol. 2006 Oct;118(4):858-65
  Andrews AL et al
  2006/01/01
  
• 備考：
  Species: Human, Application: Immunoprecipitation, Sample type: Cell Lysates
• 参照：
  

• No.： 6
• 文献情報：
  Andrews AL et al. Effect of IL-13 receptor alpha2 levels on the biological activity of IL-13 variant R110Q. J. Allergy Clin. Immunol. 2007 Jul;120(1):91-7
  Andrews AL et al
  2007/01/01
  
• 備考：
  Species: Human, Application: Neutralization, Sample type: Whole Cells
• 参照：
  

• No.： 7
• 文献情報：
  Jarboe JS et al. Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies. Cancer Res. 2007 Sep;67(17):7983-6
  Jarboe JS et al
  2007/01/01
  
• 備考：
  Species: Human, Application: IHC Paraffin-embedded, Sample type: Whole Tissue
• 参照：
  

• No.： 8
• 文献情報：
  Wykosky J et al. Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy. Clin. Cancer Res. 2008 Jan;14(1):199-208
  Wykosky J et al
  2008/01/01
  
• 備考：
  Species: Human, Application: IHC Paraffin-embedded, Western Blot, Sample type: Whole Tissue, Homogenized Tissue
• 参照：
  

• No.： 9
• 文献情報：
  Miller R et al. Development of an in vitro potency bioassay for therapeutic IL-13 antagonists: the A-549 cell bioassay. J. Immunol. Methods 2008 May;334(1-2):134-41
  Miller R et al
  2008/01/01
  
• 備考：
  Species: Human, Application: Neutralization, Whole Cells
• 参照：
  

• No.： 10
• 文献情報：
  Allen C et al. Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity. Mol. Ther. 2008 Sep;16(9):1556-64
  Allen C et al
  2008/01/01
  
• 備考：
  Species: Human, Application: IHC Fresh, Western Blot, Whole Cells, Cell Lysates
• 参照：
  

• No.： 11
• 文献情報：
  Chen W et al. Matrix metalloproteinase 8 contributes to solubilization of IL-13 receptor alpha2 in vivo. J. Allergy Clin. Immunol. 2008 Sep;122(3):625-32
  Chen W et al
  2008/01/01
  
• 備考：
  Species: Human, Application: Flow Cytometry, Whole Cells
• 参照：
  

• No.： 12
• 文献情報：
  Liu TF et al. Reoxygenation of hypoxic glioblastoma multiforme cells potentiates the killing effect of an interleukin-13-based cytotoxin. Clin. Cancer Res. 2009 Jan;15(1):160-8
  Liu TF et al
  2009/01/01
  
• 備考：
  Application: Western Blot, Sample Type: Cell Lysates
• 参照：
  

• No.： 13
• 文献情報：
  Biancheri P et al. Absence of a role for interleukin-13 in inflammatory bowel disease. Eur. J. Immunol. 2014 Feb;44(2):370-85
  Biancheri P et al
  2014/01/01
  
• 備考：
  Application: Neutralization, Sample Type: Whole Cell,cell line
• 参照：
  

• No.： 14
• 文献情報：
  Zhao Z et al. IL-13Rα2 mediates PNR-induced migration and metastasis in ERα-negative breast cancer. Oncogene 2015 Mar;34(12):1596-607
  Zhao Z et al
  2015/01/01
  
• 備考：
  Application: Western Blot, Sample Type: Cell Lysates
• 参照：
  

• No.： 15
• 文献情報：
  Mahadev V et al. Cytokine induction of VCAM-1 but not IL13Rα2 on glioma cells: a tale of two antibodies. PLoS ONE 2014;9(5):e95123
  Mahadev V et al
  2014/01/01
  
• 備考：
  Application: Flow Cytometry, Sample Type: Whole Cells
• 参照：
  

• No.： 16
• 文献情報：
  Stuckey DW et al. Engineering toxin-resistant therapeutic stem cells to treat brain tumors. Stem Cells 2015 Feb;33(2):589-600
  Stuckey DW et al
  2015/01/01
  
• 備考：
  Application: Western Blot, Sample Type: Cell Lysates
• 参照：
  

• No.： 17
• 文献情報：
  Xu J et al. Expression of surfactant protein D in airways of asthmatics and interleukin-13 modulation of surfactant protein D in human models of airway epithelium. Respir. Res. 2015;16:26
  Xu J et al
  2015/01/01
  
• 備考：
  Application: Neutralization, Sample Type: Whole Cells
• 参照：
  

• No.： 18
• 文献情報：
  Shibasaki N et al. Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma. PLoS ONE 2015;10(6):e0130980
  Shibasaki N et al
  2015/01/01
  
• 備考：
  Application: IHC - Paraffin embedded, Sample Type: Whole Tissue
• 参照：
  

• No.： 19
• 文献情報：
  Lee CM et al. IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses. Nat Commun 2016 Sep;7:12752
  Lee CM et al
  2016/01/01
  
• 備考：
  Application: Immunoprecipitation, Sample Type: Cell Lysates
• 参照：
  

• No.： 20
• 文献情報：
  Gaggianesi M et al. IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition. Cancer Res. 2017 Jun;77(12):3268-3279
  Gaggianesi M et al
  2017/01/01
  
• 備考：
  Application: Western Blot, Sample Type: Cell Lysates
• 参照：
  

• No.： 21
• 文献情報：
  Brown CE et al. Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma. Clin. Cancer Res. 2015 Sep;21(18):4062-72
  Brown CE et al
  2015/01/01
  
• 備考：
  Species: Human, Applications: Flow
• 参照：
  

• No.： 22
• 文献情報：
  Meng M et al. Cigarette smoke extracts induce overexpression of the proto-oncogenic gene interleukin-13 receptor α2 through activation of the PKA-CREB signaling pathway to trigger malignant transformation of lung vascular endothelial cells and angio
  Meng M et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 23
• 文献情報：
  Berlow NE et al. IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma. PLoS ONE 2018;13(4):e0193565
  Berlow NE et al
  2018/01/01
  
• 備考：
  Species: Human, Applications: IHC
• 参照：
  

• No.： 24
• 文献情報：
  Hegde M et al. Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape. J. Clin. Invest. 2016 08;126(8):3036-52
  Hegde M et al
  2016/01/01
  
• 備考：
  
• 参照：
  

• No.： 25
• 文献情報：
  Hegde M et al. Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma. Mol. Ther. 2013 Nov;21(11):2087-101
  Hegde M et al
  2013/01/01
  
• 備考：
  
• 参照：
  

• No.： 26
• 文献情報：
  Brown CE et al. Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma. Mol. Ther. 2018 01;26(1):31-44
  Brown CE et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 27
• 文献情報：
  Bielamowicz K et al. Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma. Neuro-oncology 2018 03;20(4):506-518
  Bielamowicz K et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 28
• 文献情報：
  Bhardwaj R et al. Identification of a novel role of IL-13Rα2 in human Glioblastoma multiforme: interleukin-13 mediates signal transduction through AP-1 pathway. J Transl Med 2018 12;16(1):369
  Bhardwaj R et al
  2018/01/01
  
• 備考：
  
• 参照：